The Synthesis and Biological Evaluation of Two Analogues of the C-Riboside Showdomycin
Jens Renner A , Irma Kruszelnicki B , Beata Adamiak C , Anthony C. Willis A , Edward Hammond D , Stephen Su B , Christopher Burns B , Edward Trybala C , Vito Ferro D and Martin G. Banwell A EA Research School of Chemistry, Institute of Advanced Studies, Australian National University, Canberra ACT 0200, Australia.
B Cytopia Pty Ltd, Baker Heart Research Institute, Commercial Road, Melbourne VIC 3004, Australia.
C Department of Clinical Virology, Göteborg University, 413 46 Göteborg, Sweden.
D Drug Design Group, Progen Industries Ltd, 2806 Ipswich Road, Darra QLD 4076, Australia.
E Corresponding author. Email: mgb@rsc.anu.edu.au
Australian Journal of Chemistry 58(2) 86-93 https://doi.org/10.1071/CH04273
Submitted: 15 November 2004 Accepted: 13 January 2005 Published: 21 February 2005
Abstract
Two novel analogues, 2 and 3, of the C-riboside showdomycin (1) have been prepared by exploiting the N-TIPS-substituted pyrrole 7 as a synthetic equivalent for the maleimide C3 anion. The tetraacetate precursor, 12, of target 2 as well as target 3 itself were subjected to single-crystal X-ray analyses. Analogues 2 and 3 as well as showdomycin and its anomer (4) have each been evaluated in various assays for their cytotoxic, anti-bacterial, and anti-viral effects.
Acknowledgments
This work was generously supported by Progen Industries Ltd and the Institute of Advanced Studies (Australian National University). We thank the Alexander von Humboldt Foundation for providing a Feodor Lynen Fellowship to J.R. Dr Gregg Whited (Genencor International Inc., Palo Alto, CA) is gratefully acknowledged for providing us with generous quantities of cis-1,2-dihydrocatechol 13. Dr Natasha Hungerford is warmly thanked for preparing samples of showdomycin (1) and its anomer (4). We are also grateful to Dr Alison Edwards for carrying out a single-crystal X-ray analysis of compound 12.
[1]
(a) C. Lamberth,
S. Blarer,
Synlett 1994, 489. and references cited therein.
| Crossref | GoogleScholarGoogle Scholar |
and references cited therein.
| Crossref | GoogleScholarGoogle Scholar |
| Crossref | GoogleScholarGoogle Scholar |
| Crossref | GoogleScholarGoogle Scholar |
| Crossref | GoogleScholarGoogle Scholar |
| Crossref | GoogleScholarGoogle Scholar |
| Crossref | GoogleScholarGoogle Scholar |
| Crossref | GoogleScholarGoogle Scholar |
| Crossref | GoogleScholarGoogle Scholar |
| Crossref | GoogleScholarGoogle Scholar |
| Crossref | GoogleScholarGoogle Scholar |
| Crossref | GoogleScholarGoogle Scholar |
| Crossref | GoogleScholarGoogle Scholar |
| Crossref | GoogleScholarGoogle Scholar |
| Crossref | GoogleScholarGoogle Scholar |
| Crossref | GoogleScholarGoogle Scholar |
| Crossref | GoogleScholarGoogle Scholar |
| Crossref | GoogleScholarGoogle Scholar |
| Crossref | GoogleScholarGoogle Scholar |
| Crossref | GoogleScholarGoogle Scholar |